AI Science Tracker

Stanford Medicine

2 discoveries from 2023 to 2024

Discoveries

SyntheMol: generated antibiotic candidates against Acinetobacter baumannii

The generative model proposed about 25,000 candidates in under nine hours from more than 130,000 synthesis building blocks; of 58 synthesized, six killed a drug-resistant A. baumannii strain and two were not toxic in mice. Mechanism unknown, efficacy in infected animals untested, and four of the six compounds were not water-soluble.

Technology: SyntheMol (generative model)

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Of 58 synthesized candidates, six killed a drug-resistant A. baumannii strain in the lab, and two of those were not toxic in mice.
  • Still unknown: Four of the six compounds were not water-soluble so were not tested in mice, efficacy in infected animals is untested, and the mechanism is unknown.
  • AI role: A generative model proposed about 25,000 candidate antibiotics and synthesis recipes in under nine hours from over 130,000 building blocks.

Evidence sources: https://med.stanford.edu/news/all-news/2024/03/ai-drug-development.html

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: press release. Paper: linked separately.

Review date: 16 Nov 2026. Review scope: Original institutional announcement checked for the specific results, AI contribution and limitations cited in the antibiotic dossier or mathematical follow-up pilot. Full-paper reanalysis, external replication and an exhaustive follow-up search were not performed..

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 221 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

A neuroprosthesis translates attempted speech at 62 words per minute

For a participant with ALS, intracortical electrodes and an AI algorithm converted attempted speech into text at 62 words per minute. With a 125,000-word vocabulary, the error rate was 23.8%, versus 9.1% for only 50 words. Proof of concept in one person, with an invasive implant and experimental device.

Technology: Neural network for phoneme decoding and language model

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: One participant with ALS attempted speech in real time; word error rates were measured at 50-word and 125,000-word vocabularies, with decoding at 62 words per minute.
  • Still unknown: The abstract states no limitations; the results come from one participant, the large-vocabulary error rate (23.8%) is substantial and decoding is well below conversational speed.
  • AI role: An AI algorithm decoded spiking activity from intracortical microelectrode arrays into text.

Evidence sources: https://med.stanford.edu/news/all-news/2023/08/brain-implant-speech-als.html · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41586-023-06377-x&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: press release. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 675 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.